JDRF’s Nicole Johnson Stresses the Need for Mental and Emotional Balance with T1D
When you have type 1 diabetes (T1D), people might see the CGM on your arm, the pump tubing, or the finger pricks. Some may even see the physical challenge of balancing food, physical activity and insulin. But what only the people who live with T1D see is the internal struggle that comes with living with […]
Closer to Cure: Renewed Funding for Type 1 Diabetes UK Immunotherapy Consortium (T1D UK)
More than 400,000 people in the United Kingdom and 1.25 million Americans have type 1 diabetes (T1D), a disease for which there is no cure yet. Type 1 Diabetes UK Immunotherapy Consortium (T1D UK), a network of British scientists, backed by Diabetes UK and Breakthrough T1D, are conducting clinical trials to find new treatments that […]
Want to Stave Off Type 1 Diabetes? Beta Cell Proliferation May Be the Key
In Nature Metabolism, Breakthrough T1D-funded researchers—including the lead author, Ercument Dirice, Ph.D., and senior author, Rohit Kulkarni, M.D., Ph.D.—found an unidentified piece of information: By enhancing beta cell mass secondary to a robust beta cell proliferation early in life, they could protect mice from developing type 1 diabetes (T1D). I’ll say that again: By enhancing […]
A DIY approach to artificial pancreas technology
Discover how the DIY approach to artificial pancreas technology is empowering people with type 1 diabetes.
Breakthrough T1D Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of Breakthrough T1D Canada
Breakthrough T1D International is deeply saddened at the loss of one of Breakthrough T1D Canada’s co-founders, Helaine Shiff. “Helaine was a remarkable woman and her legacy to our community will live on forever,” said Dave Prowten, President and CEO of Breakthrough T1D Canada. “She never let up and continued to the very end to help […]
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use in adults with T1D with a body mass index (BMI) above or equal to 27 kg/m2, in combination with insulin to improve blood-sugar control. It and Forxiga® (dapagliflozin and marketed in the United States as […]
End-stage kidney disease: A possible biomarker of 10-year risk—and therapeutic target—for people with T1D
In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of end-stage renal (kidney) disease. What’s more, over the last few decades we saw improvements in all major diabetic complications, but end-stage kidney disease rates declined the least, and it is still a cause of premature […]
What is nPOD?
The human pancreas is very difficult to study, as Breakthrough T1D-funded scientists well know. It cannot be imaged or safely biopsied from a living person. As a result, much of the research on how Type 1 Diabetes (T1D) occurs was previously conducted in animal models. While these studies taught us a great deal, they did […]
Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board of Directors has unanimously voted on and approved the appointment of Aaron J. Kowalski, Ph.D., to serve as its new President and CEO, leading Breakthrough T1D’s race to cure type 1 diabetes and to improve […]
Breakthrough T1D Nurtures the Young Adult Community by Hosting Networking Conference and Helping Secure Key Internships
More than 120 Young Adults joined Breakthrough T1D for a weekend of networking, learning and connecting at the Breakthrough T1D Young Adult Conference held in Dallas, Texas on March 30 and 31. Find the photos of this electrifying conference here. The conference experience was enriched by speakers who inspired our participants by talking about living […]
